Excerpt from the September 2024 newsletter.
- Secret Shoppers: Evidence-based treatment for opioid use disorder is widely unavailable and often discouraged by providers of residential substance use services in North Carolina [Carroll et al., open access, press release]
- Is "surveillance" a bad word? [Morabia et al., open access]
- Great discussion on naloxone pricing in North Carolina and the importance of IM naloxone, featuring CDC Director Mandy Cohen and NC AG Josh Stein at a kit making event in Raleigh [WRAL Grace Hayba]
- Secret Shoppers: $96 for Narcan® in NC Pharmacies [Marley et al., open access]
- Drug Mention with Involvement (DMI) and Polydrug Poisoning Classification Methodology Tool (DMI2EpiTool) [Slavova et al., open access software]
- This is a great new tool developed by our friends at the Univ. of Kentucky that 1) identifies drugs involved from literal text of death certificates, and 2) classifies them as polysubstance or not. This is a much-anticipated update that runs as a SAS file, and will be invaluable for state health officials. [Funded by US FDA]